PURPOSE To update the ASCO guideline on the recommended prevention and treatment
approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in …

Background: Most individuals affected by cancer who are treated with certain
chemotherapies suffer of CIPN. Therefore, there is a high patient and provider interest in …

Pharmacological strategies for chemotherapy-induced peripheral neurotoxicity (CIPN) are
very limited. We systematically reviewed data on rehabilitation, exercise, physical therapy …

Central and especially peripheral neurotoxicities due to systemic antineoplastic therapy are
common and often dose-limiting side-effects. In patients with chemotherapy (ChT)-induced …

Background This study investigated the efficacy and tolerability of wearing frozen gloves
(FGs) during chemotherapy to prevent chemotherapy-induced peripheral neuropathy (CIPN) …

Purpose The study investigates cryotherapy's efficacy in mitigating Chemotherapy-induced
peripheral neuropathy (CIPN), an adverse effect of chemotherapy that often leads to dosage …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common cause of pain and poor
quality of life for those undergoing treatment for cancer and those surviving cancer. Many …

Purpose This case-control study was designed to assess the efficacy of cryotherapy to
prevent paclitaxel-induced painful peripheral neuropathy in women with breast cancer …

Objective Chemotherapy induced peripheral neuropathy (CIPN) is an adverse effect of
certain chemotherapy agents that can result in dose reductions, permanent nerve damage …

Background Oxaliplatin-induced peripheral neuropathy (OIPN) has significant clinical impact
on the quality of life for cancer patients and is a dose limiting toxicity. Trials studying …